MINOCYCLINE HYDROCHLORIDE | N050808 | BAUSCH HEALTH US LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Medicis Pharmaceutical Corporation v. Zydus Pharmaceuticals USA Inc. et al 3 patentsANDA 203553minocycline HCl extended release | D. Del. | 2012-06-04 | Terminated 2012-12-28 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Lachman Consultant Services, Inc. - Citizen Petition FDA-2011-P-0347 · 6 docket documents Lachman Consultant Services, Inc. filed this citizen petition on behalf of a client under Section 505(j)(2)(C) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA determine Minocycline Hydrochloride Extended Release Tablets in 70 mg and 95 mg strengths are suitable for submission as | Other | 2011-05-18 | Denied | — |
Medicis Pharmaceuticals Corporation (Hunton & Williams, LLP) - Citizen Petition FDA-2009-P-0081 · 3 docket documents Medicis Pharmaceutical Corporation, represented by Hunton & Williams LLP, filed this citizen petition requesting that the FDA impose 30-month stays on approval of four ANDAs (by Sandoz, Mylan, Barr/Teva, and future applicants) for generic versions of SOLODYN® (minocycline HCl extended release tablet | 505(q) Stay Request | 2009-02-20 | Denied | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 7919483 | Mar 7, 2027 | — | — | — | — |